MicroRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling
Shumin WangiD, Eri O. MaruyamaiD, John C. MartineziD, Justin Lopes, Trunee HsuiD, Wencheng WuiD, Wei HsuiD, Takamitsu MaruyamaiD
Abstract
The ability to simultaneously modulate a set of genes for lineage-specific development has made microRNA an ideal master regulator for organogenesis. However, most microRNA deletions do not exhibit obvious phenotypic defects possibly due to functional redundancy. MicroRNAs are known to regulate skeletal lineages as the loss of their maturation enzyme Dicer impairs bone remodeling processes. Therefore, it is important to identify specific microRNA essential for bone homeostasis. We report the loss of miR-27a causing severe osteoporosis in mice. MiR-27a affects osteoclast-mediated bone resorption but not osteoblast-mediated bone formation during skeletal remodeling. Gene profiling and bioinformatics further identify the specific targets of miR-27a in osteoclast cells. MiR-27a exerts its effects on osteoclast differentiation through modulation of Squstm1/p62 whose mutations have been linked to Pagets disease of bone. Our findings reveal a new miR-27a-p62 axis necessary and sufficient to mediate osteoclast differentiation and highlight a therapeutic implication for osteoporosis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 1.07
- Field percentile
- top 27%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- miR-324 mediates bone homeostasis through the regulation of osteoblast and osteoclast differentiation and activity
D. J. Hayman, H. Lin, … D. A. Young·bioRxiv·Jul 10, 2023
- MicroRNA-378 suppressed osteogenesis of mesenchymal stem cells and impaired bone formation via inactivating Wnt/β-catenin signaling
- MicroRNA levels in bone and blood change during bisphosphonate and teriparatide therapy in an animal model of postmenopausal osteoporosis
Roland Kocijan, Moritz Weigl, … Matthias Hackl·BonePeer-reviewed·Nov 3, 2019
- Melanoregulin deficiency affects bone maintenance and lean body mass
Marta Liliana Musskopf, Vinícius de Paiva Gonçalves, … Patrícia A. Miguez·bioRxiv·Dec 17, 2025
- Increased Osteoclast Activity Contributes to Bone Resorption and Osteopenia in a Rett Syndrome Mouse Model
Nadeem Samee, Lou Belz, … Giovanni Levi·CellsPeer-reviewed·May 21, 2026
- MiR-125b differentially impacts mineralization in dexamethasone and calcium-treated human mesenchymal stem cells
Virginie Joris, Elizabeth Rosado Balmayor, Martijn van Griensven·Molecular Therapy — Nucleic AcidsPeer-reviewed·Jan 5, 2025